Patents by Inventor Lynne LeSauteur

Lynne LeSauteur has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Design of hormone-like antibodies with agonistic and antagonistic functions
    Patent number: 6610500
    Abstract: The present invention relates to an agonistic anti-human TrkA mAb 5C3 which recognizes the NGF docking site. Such antibodies may be used for the treatment, diagnosis or prevention of neurological diseases, neuromas and neoplastic tumors which express TrkA receptors. Also these antibodies may be used to develop and screen for pharmaceutical agents which are agonistic or antagonistic to NGF binding to the TrkA receptors.
    Type: Grant
    Filed: June 8, 1998
    Date of Patent: August 26, 2003
    Assignee: McGill University
    Inventors: H. Uri Saragovi, Lynne LeSauteur
  • Nerve growth factor structural analogs and their uses
    Patent number: 6017878
    Abstract: Cyclic compounds with a 3-dimensional structure that bind at least one neurotrophin receptor (NTR) under physiologic conditions in vitro or in vivo are new. Binding to NTR at least partially mimics or inhibits NT biological activity.
    Type: Grant
    Filed: August 7, 1996
    Date of Patent: January 25, 2000
    Assignee: McGill University
    Inventors: Uri H. Saragovi, Lynne Lesauteur, Claudio A. Cuello